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Chemistry and Biology of the
Streptogramin A Antibiotics

Fahim Ahmed
Department of Chemistry, Marquette University
Milwaukee, WI

William A. Donaldson
Department of Chemistry, Marquette University
Milwaukee, WI

The streptogramin A antibiotics have proven to be highly active against Gram
positive bacteria, particularly methicillin-resistant Staphylococcus aureus.
Members of this group of compounds are characterized by a 23-membered
macrocycles containing polyene, oxazole, amide and ester functionality. The
chemistry and biology of these valuable antimicrobial agents is covered.

1. Introduction
The increased use of antibiotics has led to the occurrence of
multidrug resistant strains. In particular, the emergence of methicillinresistant Staphylococcus aureus (MRSA) is recognized as a serious
problem. Recently, up to 18% of all infections in European Intensive
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Care Units were attributed to oxacillin or methicillin resistant S. aureus
[1]. These infections include skin and skin structure infections,
nosocomial pneumonia infections, and catheter related infections.
Nearly 60% of the ICU acquired S. aureus infections were reported to
be MRSA [2]. Patients with MRSA infections are linked to increased risk
of mortality (greater than twice as many deaths “on ward”) and
prolonged hospitalization (ca. twice as long) compared to patients with
methicillin susceptible S. aureus [3]. Certain risk factors are associated
with the development of MRSA infections, including previous antibiotic
use, prolonged hospitalization, severe underlying disease, old age and
multiple invasive procedures [4]. Not only is there a human toll, but
also an increased financial burden associated with these infections [5].
Thus, there is clearly the need for antibiotics effective against such
resistant pathogens. One such class of agents is the streptogramin
antibiotics. The streptogramin antibiotics, isolated from several species
of Streptomyces, may be classified into one of two subgroups. One
subgroup is peptidic in nature and is known as group B, while the
group A compounds are characterized by a 23-membered macrocyclic
ring, an oxazole ring, and a conjugated dienyl amine. This review will
primarily deal with the chemistry and biology of the group A
streptogramin antibiotics.

2. Biology of Streptogramin A Antibiotics
2.1 Isolation and Structural Assignment
The early literature of the type A streptogramin antibiotics can
be somewhat confusing due to the different names which were given
for these compounds by different research groups. For example, the
isolation of two group A streptogramin antibiotics from Streptomyces
osteogrycin (originally termed osteogrycins A and G) was reported in
1958 [6]. These were assigned the structures 1 and 2 (Fig. 1) by Todd
and co-workers in 1966 on the basis of chemical degradation, and
NMR spectroscopy and mass spectrometry [7]. A crystal structure of 1
eventually corroborated the spectroscopy-based assignment [8].
Compound 1 was also isolated from Streptomyces olivaceus ATCC
12019 [9a] (termed PA114A), from Streptomyces mitakaensis [9b]
(termed mikamycin A], from Streptomyces liodensis ATCC 11415 [9c]
(termed vernamycin A), from Streptomyces pristinaespiralis [9d]
Mini-Reviews in Organic Chemistry, Vol. 4, No. 2 (2007): pg. 159-181. DOI. This article is © Bentham Science Publishers
and permission has been granted for this version to appear in e-Publications@Marquette. Bentham Science Publishers
does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express
permission from Bentham Science Publishers.

2

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

(termed pristinamycin IIA), and from Micromonospora sp. SC 12,650
[9e] (referred to as vernamycin A). Compounds 1 and 2 are now most
frequently identified as virginiamycin M1 and M2 respectively.
A structurally related streptogramin antibiotic was isolated from
Actinomadura flava and several species of Actinoplanes, and its
structural assignment was reported as 3 (Fig. 1) by several groups
during the period 1975-79 [10]. This compound is most commonly
known as madumycin II, however different groups have variously
referred to 3 as A2314A, A15104V, A17002F, and CP-35,763. The
structure of 3 differs from the virginiamycins in that the
proline/dihydroproline group is replaced by a D-alanine unit.
Griseoviridin is a broad spectrum antibiotic isolated from
Streptomyces griseus [11]. Extensive degradation studies as well as IR
and UV spectroscopic analysis led to two proposed structures 4 and 5
for griseoviridin (Fig. 2), with the former being originally favored [12].
Eventually, the structure of griseoviridin was reassigned as 5 on the
basis of X-ray diffraction analysis [13], although one of these
references incorrectly assigned the relative stereochemistry for the
C18- C20 diol as trans. The correct stereochemistry of this group is
cis- as is indicated in structure 5 [13]. Since the configuration at C5
was known from degradation studies, this allowed for the complete
stereochemical assignment. More recently, the macrolide conformation
of griseoviridin in d6-DMSO solution was determined on the basis of 2D NMR spectroscopy and restrained molecular dynamics calculations
[14]. The solution structure is similar to that in the crystal state with
minor variations in the diendiol segment.

2.2 Biosynthetic Pathways
2.2.1 Biosynthesis of Virginiamycin M1
Kingston’s group has investigated the biosynthetic origin of
virginiamycin M1 (1) based on incorporation of 13C and 14C labeled
precursors into the antibiotic produced by Streptomyces virginiae
strain PDT 30 (Fig. 3) [15]. The antibiotic produced in the presence of
[1-13C] acetate exhibited enrichment at C5, C7, C12, C14, C16, and
C18, while 1 produced in the presence of [2-13C] acetate exhibited
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enrichment at C4, C6, C11, C13, C15, C17, as well as at C33. Notably,
growth of the microorganism fed with [1,2-13C2] acetate afforded
virginiamycin M1 which exhibited 13C-13C couplings between C4 and C5,
C6 and C7, C11 and C12, C13 and C14, C15 and C16, and C17 and
C18. Notably, there was no coupling between C12 and C33.
The most likely route for introduction of the C33 methyl group
involves aldol condensation of an individual acetate unit (presumably
in the form of malonyl CoA), followed by decarboxylation and
dehydration (Scheme 1).
Growth of S. virginiae in the presence of racemic [3-13C] serine,
produced 1 which was significantly enriched (ca. 7%) at the C20
oxazole carbon, indicative of the origin of this ring. Enrichment was
also observed at the methyl groups C32 and C33. It was proposed that
enrichment at C33 results from conversion of serine into acetyl CoA via
pyruvate, while enrichment at C32 results from methyl transfer to
methionine. To this end, microbial production of the antibiotic in the
presence of racemic [Me-13C] methionine resulted in enrichment at
C32.
Feeding [1-13C] glycine to S. virginiae resulted in 1 which was
enriched at C10 and C22. This is consistent with the N8-C9- C10
segment arising from glycine. Isotopic labeling at C22 is due to
conversion of glycine to serine by N5,N10-methylenetetrahydrofolate
and serine hydroxymethylenetransferase. Microbial production of 1 in
the presence of racemic [2-13C] valine exhibited significant 13C
enrichment only at C3.
Finally, growth of S. virginiae in the presence of radiolabeled
proline (L-[3,4-3H2] proline or L-[U-14C] proline) indicated that this
amino acid was responsible for the N23-C1 dehydroproline segment.

2.2.2. Biosynthesis of Madumycin II
LeFevre and Kingston have elucidated the biosynthetic origin of
madumycin II (produced by Actinoplanes philippinensis) using 13C and
2
H labeled precursors [16]. By analogy to the biosynthesis of
virginiamycin M2 (vide supra), the C4-C7 and C10-C18 chains are
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likely derived from acetate. Evidence in support of this was obtained in
the 13C NMR spectra of madumycin II generated in the presence of
[1,2-13C2] acetate (Fig. 4). Unfortunately, signal overlap for C11, C12,
and C13 did not allow for either detection of 13C enrichment or 13C-13C
couplings. As with virginiamycin, microbial production of madumycin II
in the presence of racemic [2-13C] valine exhibited significant 13C
enrichment only at C3.
Madumycin II produced in the presence of racemic [1,2,3-13C3]
serine exhibited 13C enrichment at the oxazole carbons C20, C21, C22,
the dienyl amine carbons C9 and C10, and at the exocyclic methyl
C30. Labeling at C9 and C10 arises due to interconversion of serine
and glycine (vide supra), while labeling at C30 presumably arises via
conversion of the labeled serine into methionine, followed by
incorporation. Notably, the madumycin produced under these
conditions did not exhibit any significant 13C enrichment at the C1,
C24, or C25 carbons of the alanine segment, thus indicating that the
biological origin of this segment is not from serine.
The biosynthetic origin of the D-alanine segment (N23,C24,C1)
was examined by feeding A. philippinensis with doubly labeled Lalanine (L-[3-13C,3,3,3-2H3] alanine). The madumycin thus produced
exhibited both 13C and three 2H labels present. Since no 2H isotopic
label was lost, the intermediacy of dehydroalanine or 24,25dehydromadumycin could be ruled out. Furthermore, competitive
incorporation of labeled L- and D-alanine indicated that there was no
preference for incorporation of either enantiomer of this amino acid.
This suggests the occurrence of a facile alanine racemase system,
which is operative prior to incorporation of D-alanine into the
madumycin skeleton.

2.3 Mode of Action
Both streptogramin type A and type B antibiotics inhibit protein
synthesis in Gram-positive bacteria [17]. Bacterial ribosomes are
comprised of a 50S and 30S subunit, which join into a 70S particle as
the initiation step for protein synthesis. The sequence of steps in
protein synthesis involve positioning of an amino acyl-tRNA (at the A
site of the ribosome) and a peptidyl-tRNA (at the P site). Peptide bond
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formation between the NH2 of the amino acyl-tRNA and the CO2H of
the peptidyltRNA is catalyzed by the peptidyl transferase center (PTC)
of the 50S ribosome, resulting in formation of an elongated chain at
the A site. The final step is for translocation of the elongated chain
from the A site to the P site in order for the process to occur again.
Type A streptogramins block the positioning of both amino acyltRNA at the A site and peptidyl-tRNA at the P site of the ribosome
[18]. However, while type A streptogramins can bind either the 50S
subunit, or the assembled 70S ribosome, it can not bind to ribosomes
already engaged in protein synthesis [19]. It is believed that these
polyene macrolides bind only to the free arms of peptidyl transferase.
Binding of streptogramin A antibiotics is believed to cause a
conformational change in the 50S subunit [20]. To this end, in vitro
incubation of the 50S subunit with virginiamycin M produced inactive
particles, even at substoichiometric quantities of the antibiotic.
Removal of virginiamycin M from these inactivated 50S particles by
column chromatography did not restore the activity.
Recently the crystal structure of virginiamycin M1 bound to the
50S ribosome of Haloarcula marismortui was reported (Fig. 5) [21].
The structure was solved to the 3.0 Å level; the location, orientation,
and conformation of 1 in the bound form was unambiguous in the
difference electron density map. The C14 hydroxyl is hydrogen-bonded
to the phosphate of A2538, the oxazole ring is positioned in a
hydrophobic pocket of the A site, with the remainder of 1 extending
over the ribosome P site. The most notable structural change upon
binding of 1 is that the conjugated amide functionality (C5-C7)
occupies an area which is originally populated by the nitrogen base of
adenosine 2103 in the native structure. This nitrogen base is rotated
ca. 90o with respect to its original position, and the plane of the
aromatic base is positioned such that it is parallel to the C5-C6 olefin.
The amide carbonyl is also hydrogen-bonded to the 2’ hydroxyl of
A2103.
The crystal structure of 1 bound to the protein Vat(D), a
streptogramin A acetyltransferase from a human urinary isolate of E.
faecium, exhibits essentially the same conformation of the macrolide
ring [22]. This type of enzyme mediates acetylation of the C14
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hydroxyl of streptogramin A antibiotics, and is linked to acquired drug
resistance in S. aureus due to drug efflux. In comparison, unbound 1
adopts a different macrolide conformation in its crystal state (as
evidenced by X-ray structure) [8], or in CDCl3, CD3OD, or d6-DMSO
solution, as determined by 2D NMR spectroscopy [23]. The solution
structures are more compact compared to those observed for bound 1.
Type B streptogramins inhibit protein synthesis by blocking
peptide bond synthesis [24]. These compounds interact with
ribosomes actively engaged in protein synthesis indicating that the
type B streptogramins bind to a portion of the PTC area distinct from
the A or P sites or the catalytic site. Thus the type A and B
streptogramin antibiotics inhibit different stages of the protein
synthesis sequence. Furthermore, the action of the two streptogramin
types is synergic. Notably, streptogramin B depsipeptides can be
displaced from the ribosomal complex by the erythromycin antibiotics.
However, in the presence of a type A streptogramin, this displacement
of the depsipeptide is not observed (i.e. tighter binding than
erythromycin). This increase in affinity for the type B streptogramin, in
the presence of a type A, is attributed to the conformational change in
the 50S subunit due to type A binding [25].
Utilization of the interaction between type A and type B
streptogramin antibiotics culminated in formulation of an injectible
mixture of two semi-synthetic streptogramin antibiotics, quinupristin
and daflopristin (3:7), approved by the FDA in 1999 and marketed
under the name “Synercid” by Aventis Pharmaceuticals (Fig. 6)[26].
Synercid is active against gram positive bacteria including vancomycin
resistant Enterococcus faecium (VREF) and methicillin-susceptible
Staphylococcus aureus (MSSA), however it is not active against E.
faecalis. This synergic interaction between type A and type B
streptogram antibiotics may have additional benefits, since bacteria
must develop resistance to the action of both type A and B inhibition.
In spite this synergic action, there are cases of quinopristindaflopristin resistant E. faecium, isolated from farm animal sources,
reported in both the USA and Europe [27]. This may be due to the FDA
approved use of Virginiamycin [a mixture of virginiamycin M and
virginiamycin S (a streptogramin type B similar to quinopristin)] in
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chickens, turkeys, swine and cattle for weight gain. However a
causative relationship between the use of Virginiamycin in animals and
resistant strains in humans could not be definitively established due to
the lack of an animal control group for comparison (i.e. animal
populations not given Virginiamycin). Limiting the use of streptogramin
antibiotics has been recommended [28] and Denmark has banned the
use of Virginiamycin as a growth-promoting agent.

3. Syntheses of Streptogramins A
3.1 Syntheses/Synthetic Studies of Virginiamycin M2
3.1.1 Schlessinger/Li Synthesis of Virginiamycin M2
Schlessinger and Li were the first to report a synthesis of
virginiamycin M2 (2) [29]. Their retrosynthetic strategy (Scheme 2)
dissected the target molecule into a C3-C7 enal (6), a C9-C16
dienylamine (7), and a metallated 2,4-oxazole (8). This strategy relied
on condensations of the anion derived from vinylogous urethanes to
set the C3 and C14 carbinol stereocenters.
Condensation of 9 with the pyrrolidine 10 (from L-proline)
followed by methylation gave the vinylogous urethane lactone 11
(Scheme 3). Deprotonation of 11 followed by reaction with isopropyl
2-bromoacetate gave a single substituted lactone 12 by alkylation on
the less hindered face. Reduction of the isopropyl ester, subsequent
protection of the 1° alcohol and Li metal reduction of the unsaturated
lactone gave the lactol 13. Oxidative elimination of the pyrrolidine
from 13 afforded the enal 14, which was protected at the t-BuPh2Si
ether (15). Horner- Emmons olefination gave the E,E-dienyl nitrile 16
which upon reduction with alane gave the dienyl amine 17.
Preparation of the C3-C7 enal began with the vinylogous
urethane 18 (Scheme 4). Aldol condensation of 18 with
isobutyraldehyde proceeded with erythro selectivity and the resultant
alcohol condensed on the ester to afford the unsaturated lactone 19
with 96% de. Dissolving metal reduction of 19 gave the lactol 20
which upon oxidative elimination of the pyrrolidine generated the
moderately stable enal 6.
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Coupling of the C3-C7 hydroxy enal 6 with N-Troc protected Dproline afforded the ester 21 (Scheme 5). Oxidation of the aldehyde
functionality with NaClO2 gave the corresponding carboxylic acid.
Condensation of acid 22 with the dienyl amine 17 under Mukiayama
conditions [30] generated the amide 23. Selective cleavage of the 1°
TBS ether in the presence of the 2° BPS ether, followed by oxidation
gave the aldehyde 24. Addition of the organozinc reagent [31] from 2bromomethyl-1,3-oxazole 25 with aldehyde 24 gave 2o alcohol 26 as
a mixture of diastereomers which were protected as their triethylsilyl
ethers 27. Reductive removal of the Troc protecting group and
hydrolysis of the oxazole methyl ester set the stage for a Mukiayama
macrolactamization to generate cyclic amide 28. Deprotection of the
TES ether under mild acid conditions, Dess-Martin periodinane
oxidation, and finally removal of the BPS with HF-pyridine completed
the synthesis of virginiamycin M2. The synthesis proceeded in 22
steps, 2.8% overall yield from lactone 9.

3.1.2 Breuilles/Uguen Synthesis of Virginiamycin M2
In 1998 Breuilles and Uguen, at the Universite Louis Pasteur,
reported a synthesis of virginiamycin M2 (a.k.a. pristinamycin IIB) [32].
Their retrosynthetic strategy (Scheme 6) was similar to that of
Schlessinger’s group; the target was dissected into a protected proline,
a C3-C7 hydroxyenoate 29, a C9-C16 dienylamine (17), and a 2,4disubstituted oxazole 30.
The C14 stereocenter inherent in the dienylamine segment 17
was derived from dimethyl (S)-malate. Reduction to the butanetriol,
followed by reaction with p-methoxybenzaldehyde gave the dioxalane
31 (Scheme 7) [32a]. Moffat oxidation of 31 afforded a sensitive
aldehyde 32 which was immediately reacted with excess ylide derived
from bromomethyltriphenylphosphonium bromide to give a mixture of
E- and Z-alkenylbromides 33. Elimination gave the alkyne 34 which
was deprotected. Selective protection of the 1° alcohol of diol 35
required considerable experimentation; eventually it was found that
slow addition of the diol to PMB trichloroacetimidate and PPTS led to
the monoprotected 36 (48%) along with unreacted 36 (23%) and
diprotected diol (11%) all of which were separable by chromatography.
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After protection of the remaining hydroxyl group, homologation was
accomplished by deprotonation with n-butyl lithium and addition to
paraformaldehyde. The 2° TMS ether was subsequently cleaved with
HF⋅pyridine to afford the diol 37. Carbometallation of 37 with
methylmagnesium chloride in the presence of 0.5 equivalents of CuI
proceeded with modest regioselectivity to give an inseparable mixture
of regioisomers 38a and 39a (1:3). Reaction of this mixture with 1.8
equivalents of diphenyl-t-butoxysilyl chloride gave a separable mixture
of disilylated 39b and monosilylated 38b. After separation, cleavage
of the silyl protecting groups from 39b gave diol 40. A sequence of
protection-deprotection steps gave 1° allylic alcohol 41 which was
oxidized to the enal 42. From this point, completion of the C9-C16
segment closely followed Schlessinger’s route (c.f. Scheme 3).
Olefination gave 43 which upon C16 protecting group exchange and
reduction of the nitrile gave dienylamine 17. The synthesis of 17 by
Breuilles and Uguen is considerably longer (21 steps) than that by
Schlessinger’s group.
The Breuilles/Uguen preparation of the C3-C7 segment relies on
the desymmetrization of the meso triol 44 (Scheme 8) [32b-d]. This
triol was prepared on multi-gram scale by Reformatsky reaction of two
equivalents of 2-bromopropanoic acid with ethyl formate to give
diacid 45 as a mixture of diastereomers. Recrystallization of the
mixture from ether gave the meso-syn,syn diastereomer 45a, which
was converted into triol 44 by diazomethane esterification followed by
reduction. Desymmetrization of the triol was accomplished by P .
fluorescens lipase catalyzed acylation [32c]. Conversion of the
remaining primary hydroxyl group of 46 into a thio ether followed by
acetate hydrolysis gave the diol 47. The diol was then transformed
into phenylsulfonate 48, which was subjected to Raney-Ni
desulfurization to give the sulfone 49 which was protected as the PMB
ether. Reaction of the anion derived from 50 with sodium iodoacetate,
followed by diazomethane esterification and cleavage of the PMB
protecting group afforded enoate 29 [32d].
Esterification of hydroxyenoate 29 with N-Boc-D-proline
followed by removal of the N-Boc protecting group gave 51 (Scheme
9). Coupling of this segment with 2-chloromethyloxazole-4-carboxylic
acid gave the amide 52. Saponification of the enoate methyl ester,
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followed by condensation with the C9- C16 dienylamine 17 afforded
the diamide 53. Selective deprotection of the TBS ether, followed by
iodide substitution and oxidation of the 1o alcohol gave 54 setting the
stage for macrocyclization. To this end, reaction of 54 with a large
excess of the chromous reagent prepared in situ from the reaction of
CrCl3 with LiAlH4 resulted in formation of the C16-C17 bond to give 28,
as a mixture of diastereomers, along with an unidentified de-iodinated
product. Preparation of 2 8 constitutes a formal total synthesis of
virginiamycin M2, since this compound was previously transformed into
2 by Schlessinger and Li (see Scheme 5). This synthesis of 2
proceeded in 28 steps (longest linear sequence); < 0.2% overall yield
from (S)-butanetriol.

3.1.3 Helquist Synthesis of the C9-C23 Segment
Prior to the Schlessinger/Li or Breullies/Uguen total syntheses,
Helquist’s group reported a synthesis of the C9-C23 diene segment
[33] utilizing nucleophilic addition of an oxazolylmethane nucleophile
to a dienal [31]. Their synthesis begins with free-radical bromination
of ethyl 3-methyl-2- butenoate, followed by a Arbuzov reaction of the
allylic halide with triethylphosphite to give the phosphonate ester 5 5
(Scheme 10).
Horner-Wadsworth-Emmons olefination of N-Bocglycinal 56 with
55 gave predominantly the E,E-dienamine 57. The stereochemistry of
the newly formed C10-C11 double bond is E- (>50:1) while the major
stereochemistry of the C12-C13 double bond is also E- (10:1).
Reduction of the ester group, followed by Swern oxidation gave the
dienal 58. Asymmetric aldol condensation of 58 with lithium (S)-N acetyl-4- isopropyl-2-oxazolidinone [34] yielded two separable
diastereoisomers 59a:59b (3:1 ratio, i.e. 50 % ee). The desired
diastereoisomer (59a) was converted into the Weinreb’s amide and
the free hydroxyl group protected as its silyl ether. Reduction of the
Weinreb’s amide with DIBAL gave aldehyde 60. Reaction of the zinc
functionalized species derived from 2- bromomethyl oxazole 61 [31]
with 60 gave a mixture of diastereomeric alcohols which upon
oxidation resulted in a single protected β-hydroxy ketone 62.
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3.1.4 Brennan/Campagne Synthesis of C9-C22 Segment
Brennan and Campagne have prepared a similar C9-C22
segment of virginiamycin M2 [35]. The synthesis begins with a
palladium-catalysed coupling of N-Boc propargylamine and methyl 2butynoate to yield 63 (Scheme 11). Reduction of the alkyne and the
methyl ester was carried out by treating 63 with LiAlH4 to give the
desired (E,E)-dienol 64. Swern oxidation of 64 yields aldehyde 65. An
asymmetric acetoacetate vinylogous Mukaiyama-aldol reaction [36] of
aldehyde 65 with the trimethylsilyloxydiene 66 in the presence of
CuF(R)-TolBINAP followed by methanolysis of the TMS ether with PPTS
yielded alcohol 67 (81% ee by chiral HPLC) which was protected as its
MOM ether (68). Reaction of 68 with TBS protected serine methyl
ester in toluene at elevated temperature gave amide 69, which was
deprotected by treatment with HF-pyridine. The resulting amido
alcohol was cyclized with diethylaminosulfurtrifluoride (DAST) [37]
under basic condition to afford an oxazoline. Dehydrogenation of the
oxazolidine using NiO2 proceeded in only 34% yield to give the oxazole
70.

3.1.5 Ahmed/Cao/Donaldson Synthesis of C9-C17
Ahmed, Cao and Donaldson have prepared a C9-C17 segment of
virginiamycin M2 [38a]. Their synthesis begins with the known [39]
E,E-dienal-iron complex 71 (Scheme 12) . Reaction of 71 with
benzylamine followed by NaBH4 reduction and protection gave the NBoc derivative 72. The ester complex was transformed into the triene
73 by reduction, Saigo-Mukaiyama oxidation [40], and finally Peterson
olefination. Cycloaddition of 73 with the nitrile oxide derived from 2(2-nitroethoxy)tetrahydropyran gave isoxazoline 74 as a mixture of
diastereomers at the THP carbon. The diastereoselectivity of this
cyclocondensation results from approach of the nitrile oxide to the
complexed triene in the s-trans conformer on the face opposite to the
bulky (tricarbonyl)iron group (Fig. 7). The s-trans conformer is the
predominant conformer in solution due to destabilizing steric
interactions in the s-cis conformer. Reductive hydrolysis of isoxazoline
74 in the presence of commercially purchased Raney-Ni gave βhydroxyketone 75 as a mixture of diastereomers at the THP carbon.
While the diastereoselectivity of the intermolecular nitrile oxide-olefin
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cycloaddition was demonstrated on a racemic (triene)iron complex,
preparation of the precursor (71) in optically active form would lead to
an enantioselective synthesis [38b].

3.1.6 Helquist Route to the C3-C7 Segment of the
Virginiamycins/Madumycins
Helquist’s group has described a short route to the C3-C7
segment 76 of the virginiamycins/madumycins [41]. This synthesis
utilizes a diastereoselective aldol condensation between N-propionyl
oxazolidinethione 77 and isobutyraldehyde to afford 78 (Scheme 13).
Protection of the C3 alcohol, reductive removal of the chiral auxiliary,
and olefination complete the synthesis. The Wittig olefination
proceeded with 18:1 E:Z selectivity, and the two geometrical isomers
could be separated by column chromatography.

3.2 Synthesis of 14,15-Anhydropristinamycin IIB
14,15-Anhydropristinamycin IIB (79, Scheme 14) is a
streptogramin A antibiotic related to virginiamycin M2; the
dehydroproline derivative has been isolated from S. olivaceus
ATCC53527 [42]. Pattenden’s group has reported a total synthesis of
79 which relies on a Stille-type Pd-catalyzed vinyltin coupling [43]
strategy for closure of the macrocyclic ring. Their retrosynthetic
analysis dissects the target molecule into a vinyl-tin amide segment
80, a dienal bromide 81, and oxazole 82 (Scheme 14) [44].
Preparation of the vinyl-tin amide segment (C3-C11) begins
with a diastereoselective aldol condensation between the N-propionyl
oxazolidinone 83 [34] and isobutyraldehyde to afford 84 (Scheme
15). Reductive removal of the chiral auxiliary with Red-Al, followed by
Horner-Emmons olefination gave the unsaturated ester 85. Protection
of the C3 alcohol, followed by amide formation with propargylamine
gave 86. The MOM protecting group was removed and replaced by an
acetyl group. Hydrostannylation of the propargyl amide gave the vinyltin species 87. Saponification of the acetyl group gave the alcohol 80.
Preparation of the C12-C16 dienal bromide 81 began with
oxidation of the known allylic alcohol 88 to afford the enal 89 (Scheme
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16). Horner-Emmons olefination, followed by reductive removal of the
Weinreb’s amide gave 81. Reaction of the dianion generated from 4hydroxymethylene-2-methyl-1,3- oxazole (82) with 81 gave the
racemic dienol 90 in modest yield. Selective oxidation of the C23
hydroxymethylene group in the presence of the C16 dienyl alcohol was
accomplished using MnO2 to afford aldehyde 91. The authors propose
that this selectivity may be due to prior association of the C16 dienyl
hydroxyl group with the oxazole nitrogen which protects this group
from reaction. Oxidation of the oxazole carboxaldehyde gives
carboxylic acid 92.
Coupling of the C3-C11 alcohol 80 with N-trifluoroacetyl Dproline, followed by hydrolysis of the TFA group gave 93 (Scheme 17).
Further coupling of carboxylic acid 92 with 93 gave the vinyl
stannane-vinyl bromide acyclic precursor 94 as a mixture of
diastereomers at C16. Palladium catalyzed intramolecular Stille
coupling [43] of 94 with Pd2(dba)3 and triphenylarsine afforded the
macrocyclic trienol 95, albeit in low yield. Oxidation of the alcohol
completed the synthesis of anhydropristinamycin IIB. The synthesis
proceeded in 14 steps, 1.3% overall yield from 83.

3.3 Syntheses/Synthetic Studies of Madumycin IIB
3.3.1 Meyers’ Synthesis of Madumycin II
Meyers' group has reported a total synthesis of madumycin IIB
[45]. Their strategy required dissecting 3 into two major components
96 and 97 by disconnection at the two amide bonds (Scheme 18).
Meyers route to the C9-C23 segment 96 began with
transformation of (S)-malic acid into the Weinreb’s amide 98 by 1)
Fischer esterification, 2) chelation controlled borane reduction, 3) 1,2diol protection, and 4) conversion to the amide (Scheme 19). Reaction
of 98 with allyl magnesium bromide generated the β,γ-enone which
underwent stereoselective reduction (>99% de) with LiAlH4 and LiI to
afford the homoallylic alcohol 99. Protection of the secondary alcohol,
ozonolysis and chlorate oxidation yielded the carboxylic acid 100. The
carboxylic acid was converted into the requisite oxazole 101 by 1)
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generation of the mixed anhydride with isobutylchloroformate, and
amide formation with (S)-serine methyl ester, 2) cyclization to the
oxazoline with Burgess reagent [46], and 3) oxidation of the oxazoline
to oxazole with Cu(II)-Cu(I) peroxide reagent [47]. Deprotection of
the C16 TBS ether followed by reaction with the dimethyl acetal of (2mesityl)formaldehyde in the presence of a catalytic amount of
camphorsulfonic acid gave the acetal 102. Swern oxidation of the 1°
alcohol and Wittig olefination with α-formylethylidine
triphenylphosphorane afforded the (E)-α,β-unsaturated aldehyde 103.
Reaction of enal 103 with vinyl tributylphosphonium bromide and
potassium phthalimide yielded the E,E-dienylamine, and removal of
the methyl ester gave the oxazole carboxylic acid 96 (18 steps, 4.6 %
overall yield).
Meyers’ construction of the northern fragment of the macrolide
utilized an Evans’ diastereoselective aldol condensation, similar to that
reported by Pattenden (c.f. Scheme 15) to generate the alcohol 84.
The acyl oxazolidinone 84 was converted into its corresponding
Weinreb amide which was reduced to the aldehyde (Scheme 20).
Olefination with diethyl 2-trimethylsilyl-ethyl phosphonoacetate gave
104 as the pure (E)- isomer. The resulting alcohol was coupled with NBoc-Dalanine followed by toluenesulfonic acid mediated removal of the
Boc protecting group afforded amino ester 97.
Dicyclohexyl carbodiimide (DCC) mediated coupling of amine 97
with acid 96 afforded the amide 105 in good yield (Scheme 21).
Removal of the phthalimide protecting group was carried out by
treating 105 with methylamine in ethanolbenzene mixture at 50ºC for
2 days. Cleavage of the β-silylethylester was accomplished by treating
with TBAF to yield 106. Finally coupling of the primary amine with the
C7 carboxylic acid was carried out by treating 106 with i-Pr2EtN and
bisoxazolidinone phosphoryl chloride (BOPCl) to yield 107. Hydrolysis
of the acetal protecting group in 107 gave madumycin II (3) with 8-10
% of a double bond isomer impurity. The Meyers synthesis requires 18
steps for the preparation of diene fragment 96 from (S)-malic acid and
an additional 5 steps to couple 97 with 96 to form 3.
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3.3.2 Ghosh’s Synthesis of Madumycin II
Ghosh’s group adopted a linear synthesis strategy to make
madumycin II. Their retrosynthetic strategy dissected the molecule
into a dienyl azide (108) and the unsaturated carboxylic acid (109)
(Scheme 22) [48].
Desymmetrization of the meso-cyclopentane-3,5-diacetate 110
by enzymatic hydrolysis according to the procedure of Schefold [49],
yielded alcohol 111 in 95% ee (Scheme 23). Protection of 111
followed by ozonolysis and NaBH4 reduction gave the diol 112.
Transesterification of the acetate with methanol and protection of the
resultant 1,2-diol with 2,2-dimethoxypropane resulted in the formation
of 113. Oxidation and olefination, in a fashion similar to that of Meyers
(c.f. 102 –> 103, Scheme 19), gave the enal 114. Horner-Emmons
olefination of 114 gave the E,E-dienoate 115. Transformation into the
dienyl azide 116 was accomplished by reduction with DIBAL,
generation of the mesylate and subsequent SN2 displacement with
sodium azide. Selective removal of the acetonide in the presence of
the MOM ether was accomplished by treatment with methanolic pTsOH. Mesylation of the 1º alcohol followed by SN2 displacement with
cyanide gave nitrile 117 which was hydrolyzed to carboxylic acid 118.
Treatment with BOP and diisopropylamine in the presence of silyl
protected L-serine methyl ester gave the amide, which upon protection
of the C16 hydroxyl group with MOMCl furnished 119. Conversion of
119 to the oxazole 108 required 1) silyl ether deprotection with
fluoride ion, 2) Burgess reagent [46] mediated cyclization to an
oxazoline, and 3) oxidation to the oxazole by treatment with CuBr2,
DBU, and HMTA [50].
Syn-homoallyl alcohol 120 was synthesised in >95% ee by
reaction of the chiral (Z)-crotyl borane 121 [51] with isobutyraldehyde
followed by oxidative workup (Scheme 24). The terminal vinyl group
of 120 was subjected to ozonolytic cleavage and subsequent HornerEmmons olefination gave the α,β-unsaturated ester 85. The secondary
alcohol was then protected as the THP ether, followed by
saponification to give carboxylic acid 109.
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Saponification of methyl ester 108 with aqueous LiOH followed
by workup with dilute acid gave the corresponding carboxylic acid
which was coupled with D-alanine methyl ester to afford 122 (Scheme
25). Reduction of the azide functionality gave the primary amine 123.
Amine segment 123 and acid segment 109 were joined by amide
formation to afford 124. The THP protecting group was removed under
acidic conditions followed by saponification of the C23 ester to afford
125. Yamaguchi macrolactonization between the C2 hydroxyl group
and the C23 carboxylic acid affords 126. Exposure of 126 to
tetrabutylammonium bromide and an excess of dichlorodimethylsilane
removes both of the MOM protecting groups of the 1,3-diol which
concluded Ghosh’s synthesis of madumycin II (3). The Ghosh
synthesis requires 19 steps for the preparation of diene segment 108
from 3,5-diacetoxy cyclopentene and an additional 8 steps to complete
the synthesis of 3 (0.68% overall yield).

3.4 Syntheses/Synthetic Studies of Griseoviridin
3.4.1 Meyers’ Synthesis
Meyers' group has reported the only total synthesis of
griseoviridin [52]. Their retrosynthetic strategy divided the molecule 5
into a C11-C24 oxazole-diene 127 and the ninemembered vinyl sulfide
macrolide 128 which would be joined using amide bond formation
(Scheme 26).
The preparation of diene segment began with the protected triol
102, previously prepared from (S)-malic acid in the Meyers’ synthesis
of madumycin IIB (c.f. Scheme 19) [47]. Oxidation of 102, followed
by Wittig olefination with allyltriphenylphosphonium bromide gave
diene 129 as a mixture of E- and Z-isomers (5:1, Scheme 27).
Photolysis of this mixture in the presence of I2 gave exclusively the Eisomer, which upon hydrolysis with LiOH gave the carboxylic acid 127.
Condensation of the enolate anion from allyl acetate with
(S)-3-t-butyldimethylsilyloxybutanal, followed by oxidation with DessMartin periodinane gave the β-ketoester 130 (Scheme 28). Reaction
of the anion of 130 with the electrophilic sulfur agent 131 proceeded
with formation of the carbon-sulfur bond to give 132. The
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configuration at this newly formed chiral center was irrelevant since
reduction of the ketone functionality, mesylation of the resultant
alcohol, and elimination gave the vinyl sulfide 133 (20:1, Z:E).
Treatment of 133 with 10% HCl resulted in removal of both the TBS
ether and hydrolysis of the t-butyl ester. Cyclization of the hydroxy
acid 134 was accomplished under Mitsunobu conditions [53] to give
the macrolide 1 3 5 with inversion at C5. The trichloroethoxycarbonyl
protecting group was removed by reduction over Cd/Pb to afford the
amino lactone 128. Many of these steps had been previously
pioneered by Miller’s group (c.f. Scheme 32).
Coupling of amino lactone 128 with the oxazole carboxylic acid
127 gave the amide 136 (Scheme 29). Conversion of the allyl ester to
the carboxylic acid under Pd-catalysis, followed by amide bond
formation with allyl amine gave the cyclization precursor 137.
Treatment of 137 with 30 mol % Grubbs’ “1st generation catalyst”
[54] proceeded with formation of the macrolide 138 as a single olefin
stereoisomer. Attempts to optimize the RCM conditions resulted in
yields in the 37-42% range. Hydrolysis of the mesityl acetal gave
griseoviridin (5). The Meyers synthesis requires 17 steps from (S)malic acid for the preparation of diene carboxylic acid 127 and an
additional 5 steps to couple 127 with 128 to form 5.

3.4.2 Ghosh/Lei Synthesis of C11-N26 Dienyloxazole Segment of
Griseoviridin
Ghosh and Lei have reported a synthesis of the C11-N26
fragment (139, Scheme 30) of griseoviridin [55]. Allylation of
benzyloxyacetaldehyde gives racemic alcohol 140 which upon lipase
catalyzed acylation afforded a separable mixture of unreacted (S)-140
and the optically active acetate (R)-141. Conversion (R)-141 into
additional (S)-140 was accomplished by: i) saponification, ii)
Mitsunobu inversion [53] with p-nitrobenzoic acid, and iii)
saponification. Esterification of (S)-140 with acryloyl chloride and ringclosing metathesis with Grubbs’ 1st generation catalyst in the presence
of Ti(OiPr)4 [56] gave the unsaturated lactone 142. Epoxidation of 1 4
2 proceeded in a diastereoselective fashion, and the resultant epoxide
143 was reductively opened with diphenyldiselenide/NaBH4 in
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isopropanol to afford the ester 144. Removal of the benzyl protecting
group and selective protection of the 1,3-diol functionality gave
145. The dienyl chain was installed by oxidation of the primary
alcohol, Wittig olefination, addition of vinyl Grignard to the enal 146
and acylation of the resultant secondary alcohol to afford acetate 147
as a mixture of diastereomers. A palladium catalyzed dienyl acetate
substitution with sodium azide gave 148 as the E,E-isomer.
Conversion of the ester 148 into oxazole 139 was accomplished by a
combination of methods used by Ghosh [48] and Meyers [45] in their
syntheses of madumycin II (c.f. Schemes 19 and 22). The preparation
of 139 requires 17 steps from benzyloxyacetaldehyde.

3.4.3 Helquist Preparation of the Aminolactone Segment of
Griseoviridin
There are many synthetic studies reported for the aminolactone
segment of griseoviridin. Helquist’s group reported a synthesis of the
aminolactone segment in 1985 (Scheme 31) [57]. Aldol condensation
of 1,3-oxathiolanone 149 with (S)-3-tetrahydropyranyloxy-butanal
gave a mixture of diastereomeric alcohols 150. Mesylation followed by
base mediated elimination gave 151 as a 2.5:1 mixture of E:Z
isomers. Methanolysis of 151 gave the ester 152, exclusively as the
Z-isomer. Reaction of the anion from 152 with the protected (S)iodomethyleneglycine 153 afforded the S-alkylation product 154.
Hydrolysis of the THP ether as well as the diphenylmethyl ester,
followed by Mitsunobu cyclization [53] gave the aminolactone 155.

3.4.4 Miller’s Synthesis of a Diastereomeric Aminolactone
Miller’s group reported a synthesis of an aminolactone
diastereomeric at the C8 center with respect to griseoviridin (Scheme
32) [58]. This difference in configuration is due to Miller’s use of the
less expensive L-cystine as a starting material. Esterification as the tbutyl ester and Cbz protection of the amino group gave 156.
Treatment of the protected cystine with sulfuryl chloride followed by
reaction with potassium phthalimide gave an electrophilic sulfur
transfer agent 157.
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Baker’s yeast mediated reduction of ethyl acetoacetate gave
ethyl (S)-3-hydroxybutanoate [59]. Protection of the alcohol and
saponification of the ester gave the carboxylic acid 158. Reaction of
the carboxylic acid with carbonyldiimidazole and the magnesium salt of
monomethyl malonate gave the β-keto ester 159. Reaction of the
anion of 159 with the electrophilic sulfur agent 157, followed by
ketone reduction, mesylation, and base mediated elimination afforded
160. These steps were later utilized by Meyers’ group in their
synthesis of the correct diastereomer of the aminolactone segment
(c.f. Scheme 28). Hydrolysis of the TBS ether, followed by cleavage of
the t-butyl ester and Mitsunobu cyclization [53] completed preparation
of the diastereomeric aminolactone 161.

3.4.5 Marcantoni/Bartoli Preparation of Aminolactone
The groups of Marcantoni and Bartoli reported a synthesis of the
aminolactone segment involving an aldol condensation between (S)-3MOMO-butanal (162) and an S-alkylated 2-thioacetate (163) (Scheme
33) [60]. The aldehyde segment was prepared by Baker’s Yeast
mediated reduction of ethyl acetoacetate [59]. In this case, the
authors determined the enantiomeric excess to be 95.4% on the basis
of Mischer’s ester technique [61]. Protection of the secondary alcohol
and DIBAL reduction of the ester gave 162. Protection of D-cystine as
its benzamide and t-butyl ester, followed by NaBH4 reduction of the
disulfide bond gave the protected D-cysteine 164. Alkylation of 164
with ethyl bromoacetate afforded 163. Generation of the magnesium
anion of 163 and coupling with aldehyde 162 in the presence of CeCl3
gave the alcohol 165 as a mixture of diastereomers. In this case,
attempted mesylation/ elimination of 165, in a fashion similar to that
pioneered by Miller, (Scheme 32) resulted in a “complex mixture of
elimination products.” This difficulty was eventually overcome by use
of CeCl3/NaI to give the vinylsulfide 166. These reaction conditions
also effected hydrolysis of the MOM ether and t-butyl ester. Mitsunobu
cyclization [53] of 166 gave the aminolactone 167.

3.4.6 Ardisson’s Preparation of a Diastereomeric Aminolactone
Ardisson’s group reported preparation of a diastereomeric
aminolactone (Scheme 34) [62] similar to that reported by Miller. The
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French group however utilized a unique strategy compared to those
outlined above. Reaction of (S)-propylene oxide with lithium acetylide
gave (S)-1-pentyn-4-ol, which was protected as its triethysilyl ether
(168). Deprotonation of 168 and reaction with the electrophilic sulfur
agent 169, derived from L-cystine, gave the alkynyl sulfide 170.
Removal of the TES protecting group, saponification of the methyl
ester and Mitsunobu cyclization [53] gave the alkynyl lactone 171.
The requisite ester functionality was introduced by Pd-catalyzed
hydrostannylation of 171, followed by tin-halogen exchange to afford
the vinyl iodide 172. A Pd-catalyzed methoxycarbonylation completed
the synthesis of the diastereomeric aminolactone segment 173.

3.4.7 Ardisson’s Second Generation Approach to the
Aminolactone Segment
More recently, Ardisson’s group reported a very short, albeit
non-stereoselective and lower yielding, approach to the aminolactone
segment of griseoviridin (Scheme 35) [63]. Reaction of (S)-propylene
oxide with the anion derived from lithio ethyl propynoate gave alkynol
174. Esterification of bis-N-Boc L-cystine with 174 afforded 175;
notably, both chiral centers are opposite in configuration to that
required for naturally occurring griseoviridin. Zinc/acetic acid mediated
reduction of the disulfide bond of 175 and work-up with silver nitrate
gave the diastereomeric aminolactones (8R)-176 and (8S)-176 which
were separable by column chromatography. Presumably, reduction of
175 proceeds with epimerization at the C8.

4. Conclusion
The streptogramin A macrolides are effective antibiotics,
particularly when combined with the streptogramin B cyclic
polypeptides. These agents act to halt protein synthesis against
Gram-positive bacteria by binding to the 50S or 70S ribosomes. The
complex structure of the streptogramin A antibiotics combined with
their impressive biological activity has generated considerable
synthetic interest, culminating in total syntheses of virginiamycin M2
(2), madumycin IIB (3), 14,15- anhydropristinamycin (81), and
griseoviridin (5). Additionally, due to the wide variety of chemical
functionality present in these molecules, these synthetic studies have
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resulted in the development of methodology which can be applicable to
a wide variety of naturally occurring targets.
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Figure 7
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